What Is a Delayed Reaction? Definition and Classification
Complications following filler injections are divided into two groups based on timing:
- Early phase (0–4 weeks): Directly related to the procedure — oedema, bruising, asymmetry, vascular occlusion, superficial necrosis.
- Late / delayed phase (4 weeks and beyond): Swelling, firmness, redness and lumping appearing weeks, months or even years after the procedure. Complications in this phase have very different mechanisms and must be treated accordingly.
The incidence of delayed reactions is reported in the literature at between 0.02% and 0.4%; however, the true incidence is thought to be higher due to under-reporting.
Delayed Reaction Mechanisms: Four Main Types
| Mechanism | Onset Timing | Symptoms | Treatment |
|---|---|---|---|
| Delayed hypersensitivity (Type IV) | Weeks to months later | Symmetrical, bilateral swelling; possible itching; no fever | Oral corticosteroid, hyaluronidase |
| Biofilm | Months to years later | Asymmetric, nodular, partially red; temporary response to antibiotics | Long-course antibiotics, hyaluronidase |
| Foreign-body granuloma | Months to years later (especially with permanent fillers) | Firm, painless nodule; does not move over the skin surface | Intralesional steroid / 5-FU / hyaluronidase |
| COVID-19 / vaccine-triggered reaction | 24–48 hours after COVID or vaccination | Acute swelling at previous filler sites; old treatment areas become reactive | Antihistamine, oral steroid, hyaluronidase |
COVID-19-Associated Delayed Filler Reactions
An important phenomenon observed during the pandemic: patients with hyaluronic acid filler who developed sudden swelling at filler sites following SARS-CoV-2 infection or mRNA vaccination. This was first published as a case series in 2021 following vaccination (Cohen et al., JAMA Dermatology 2021).
Clinical presentation:
- Oedema / swelling at previous filler sites begins within 12–72 hours of infection or vaccination
- Multiple sites can be affected simultaneously (all previous filler areas)
- Generally resolves spontaneously within 2–4 weeks
- Thought to be related to immune system activation (toll-like receptor pathway)
Management: Most cases can be managed with oral antihistamines and a short course of oral corticosteroids. In severe cases, dissolution of the filler with hyaluronidase is considered. It is recommended that patients be informed of this possibility in advance (as part of informed consent).
Biofilm: Diagnosis and Treatment
Biofilm refers to bacterial colony structures formed on the surface of filler material that exhibit high antibiotic resistance. The clinical picture is insidious:
- After remaining silent for months, it can be activated by a trigger (dental procedure, upper respiratory tract infection, immunosuppression)
- Classic infection signs (fever, leucocytosis) are generally absent
- Culture results are usually negative — bacteria within the biofilm are not captured by standard culture methods
Biofilm antibiotic protocol (recommended):
- Clarithromycin 500 mg + metronidazole 400 mg — twice daily for 4–6 weeks
- Alternative: ciprofloxacin + metronidazole combination
- In addition to antibiotic therapy, dissolution of the filler with hyaluronidase is preferred in the long term — because the filler material continues to provide a substrate for biofilm formation
Granuloma Treatment
Foreign-body granulomas are more common with permanent or semi-permanent filler materials (PMMA, polyacrylamide, silicone) but can also rarely develop with HA fillers. Treatment options:
- Intralesional corticosteroid (triamcinolone 10–40 mg/ml): First-line treatment. Applied with monthly injections. Careful dose adjustment is required due to the risk of tissue atrophy.
- Intralesional 5-fluorouracil (5-FU): Used alone or in combination with steroids. Reduces fibrosis and granulomatous reaction.
- Hyaluronidase: Breaks down the material in HA-based granulomas and reduces granuloma burden. Not effective with permanent fillers.
- Surgical excision: Last resort for resistant, large or superficial granulomas.
What Is the Role of Hyaluronidase in Delayed Reactions?
Hyaluronidase is an enzyme that breaks down hyaluronic acid and is used for various purposes in delayed reactions:
- In hypersensitivity reactions: Reduces the HA antigenic load and resolves inflammation
- In the presence of biofilm: Dissolves the filler, eliminating the matrix to which bacteria adhere (used alongside antibiotics)
- In HA granuloma: Reduces granuloma mass and facilitates steroid treatment
Important note: If the delayed reaction originates from biofilm, hyaluronidase alone is insufficient — recurrence is inevitable unless the bacterial source within the biofilm is eliminated. Furthermore, hyaluronidase does not work for all filler types — it is effective only with HA-based fillers and cannot be used with PMMA, Radiesse or permanent materials.
Preventive Strategies
Measures that clinicians can take to reduce the risk of delayed reactions:
- Postponing filler treatment during active dental infection or systemic illness
- Planning the procedure at least 2–4 weeks before or 2–4 weeks after vaccination for patients receiving vaccines (particularly COVID vaccines)
- Preferring HA over permanent or semi-permanent materials (particularly in immunosuppressed patients)
- Recommending amoxicillin prophylaxis to filler patients before dental procedures (in cases with high biofilm risk)
- Screening patients for chronic infection foci (dental, sinusitis) before the procedure
You can book an expert physician consultation at Virtuana Clinic for the management of filler complications. Reactions to filler administered at another clinic can also be assessed at our clinic. Please contact us for pricing information.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.